Cancer Grand Challenges Awardees Announced
National Cancer Institute
The Cancer Grand Challenges program, funded by the National Cancer Institute and Cancer Research UK, will award $100 million to four interdisciplinary teams from around the world to solve some of the toughest challenges in cancer research. Each team will receive $25 million over five years. The teams include researchers from a number of AACI cancer centers.
Read More
$11 Million Grant to Improve Immunotherapy for Lung Cancer
Winship Cancer Institute of Emory University
Winship Cancer Institute of Emory University has been awarded an $11 million grant from the National Cancer Institute to support research aimed at improving the effectiveness of immunotherapy for lung cancer in patients with a mutation of the LKB1 gene. The research is led by Haian Fu, PhD, and Suresh Ramalingam, MD.
Read More
$10 Million Gift to Establish Brock Family Center for Applied Innovation
Vanderbilt-Ingram Cancer Center
A $10 million gift from the Brock family will establish the Brock Family Center for Applied Innovation at Vanderbilt University Medical Center. The gift will accelerate translation of discoveries through commercialization and industry partnerships. John Brock III is the retired CEO of Coca-Cola European Partners PLC, formerly Atlanta-based Coca-Cola Enterprises, Inc.
Read More
$5 Million to Establish New Urologic Cancer Program
UK Markey Cancer Center
The UK Markey Cancer Center has received a $5 million gift to establish the Ambassador William Stamps Farish Program of Excellence in Urologic Cancer.
Read More
Four NYC Cancer Centers Receive $1 Million to Improve Lung Cancer Care in Underserved Patients
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health
A team of New York City lung cancer experts, led by investigators at NYU Langone Health's Perlmutter Cancer Center, have received a three-year, $1 million grant from Stand Up To Cancer® (SU2C) to bring technology-enabled immunotherapy monitoring to under-represented patient populations.
Read More
Back to News From the Centers
Mayo Announces New Leadership Structure
Mayo Clinic Comprehensive Cancer Center
Three Mayo Clinic Cancer Center leaders have assumed new roles: Stephen M. Ansell, MD, PhD, has been named enterprise deputy director and senior deputy director, Midwest; Roxana Dronca, MD, has been named director, Florida Cancer Programs; and Alan Bryce, MD, will serve as acting director, Arizona Cancer Programs.
Pictured, clockwise from top right: Stephen M. Ansell, MD, PhD; Roxana Dronca, MD; and Alan Bryce, MD
Read More
Radiation Oncology Chair Appointed
UPMC Hillman Cancer Center
Heath D. Skinner, MD, PhD, has been appointed chair of the Department of Radiation Oncology, effective July 1. Clinically, he will focus on advancing UPMC Hillman Cancer Center’s radiation oncology services nationally and enhancing access to care.
Read More
New Director for Thoracic Oncology Research Initiative
University of Colorado Cancer Center
For Sharon Pine, PhD, racial and economic disparities in cancer diagnosis and care add an urgency to lung cancer research. Dr. Pine will bring that motivation to her new role as director of the Thoracic Oncology Research Initiative (TORI) at the University of Colorado Cancer Center.
Read More
COE Leadership Team Announced
Mayo Clinic Comprehensive Cancer Center
Mayo Clinic Cancer Center has announced a new community outreach and engagement (COE) leadership team to help develop targeted interventions that will lead to sustainable, impactful changes in health equity.
Read More
Palmer Named VP Of Cancer Clinical Administration and Strategy
Winship Cancer Institute of Emory University
Stacy L. Palmer, MBA, has joined Winship Cancer Institute of Emory University as the new vice president of cancer clinical administration and strategy. She will be responsible for coordinating clinical strategy and supporting standardization of cancer care across clinical sites and partners.
Read More
Scientist Tapped to Lead Basic Science Research
Roswell Park Comprehensive Cancer Center
A research leader with a record of important discoveries in cancer biology and precision therapeutics, Roswell Park’s Erik Knudsen, PhD, has been promoted to associate director of basic science research.
Read More
New Associate Director of Translational Research Welcomed
University of Colorado Cancer Center
With more than 20 years of experience in gene therapy and personalized medicine, Hatim Sabaawy, MD, PhD, steps into the role of associate director of translational research at the University of Colorado (CU) Cancer Center on July 1. Dr. Sabaawy joins CU from Rutgers University in New Jersey.
Read More
New Vice President of Cancer Services Announced
WVU Cancer Institute
Edward Harrison has joined the WVU Cancer Institute as its vice president of cancer services. His first day on the job was May 16. Prior to WVU, he served in various leadership roles at UPMC and the University of Pittsburgh.
Read More
Back to News From the Centers
Rectal Cancer Disappears After Experimental Use of Immunotherapy
Memorial Sloan Kettering Cancer Center
A small clinical trial conducted by Memorial Sloan Kettering Cancer Center found that every rectal cancer patient who received an experimental immunotherapy treatment had their cancer go into remission.
Read More
Blood Test Developed to Predict Liver Cancer Risk
Simmons Comprehensive Cancer Center, UT Southwestern Medical Center
An estimated one-quarter of adults in the U.S. have nonalcoholic fatty liver disease (NAFLD), an excess of fat in liver cells that can increase the risk of liver cancer. Now, UT Southwestern researchers have developed a simple blood test to predict which NAFLD patients are most likely to develop liver cancer.
Read More
Liquid Biopsy Detects DNA Markers in Advanced Breast Cancer Within Five Hours
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can accurately detect the presence of cancer DNA in the blood of patients with metastatic breast cancer within five hours.
Read More
New Lung Cancer Screening Guidelines Reduce Disparity
Sidney Kimmel Comprehensive Cancer Center at Jefferson
Cancer screening guidelines published last year expand eligibility for those at high risk for lung cancer, and new research shows that they also improve representation among African American patients.
Read More
Discovery Could Revolutionize Understanding of Aggressive Cancer Growth and Spread
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
New data show that ammonia—typically known as a waste byproduct from protein degradation that is excreted from the human body through urine—plays a key role in fueling the rapid growth of certain aggressive forms of cancer.
Read More
Solid Tumors Use a Type of T Cell as Shield Against Immune Attack
Fred Hutch Cancer Center
An unexpected trick in cancer’s playbook may fool an important component of our immune systems into knocking down our natural defenses against solid tumors. Scientists at Fred Hutchinson Cancer Research Center say this newfound vulnerability involves a misuse of a type of T cell, part of a large family of blood cells that are essential to a functioning immune system.
Read More
Androgen Receptor Signaling Contributes to Targeted Therapy Resistance in Melanoma
The University of Texas MD Anderson Cancer Center
Androgen receptor signaling affects response to BRAF/MEK inhibitor therapy in both males and females with melanoma, researchers from MD Anderson Cancer Center showed in a new study. The findings provide a new target to combat therapeutic resistance and one possible answer to why men face a poorer prognosis than women when diagnosed with melanoma.
Read More
Computer Simulations of Proteins Help Unravel Why Chemotherapy Resistance Occurs
Stony Brook Cancer Center
A team of scientists from Stony Brook Cancer Center and Renaissance School of Medicine at Stony Brook University believe they have found a new process through which drug resistance happens. A computer simulation model is helping them understand how molecules interact with Imatinib in the chemotherapy resistant process.
Read More
Hormones Contribute to Sex Disparities in Bladder Cancer, Study Shows
Cedars-Sinai Cancer
Male sex hormones interfere with the body’s ability to fight bladder cancer, likely explaining why males experience higher cancer rates and more deadly disease, according to a new study co-led by a Cedars-Sinai Cancer investigator.
Read More
Tumor-Based Methylation Patterns Identified as Cancer Biomarkers
Moffitt Cancer Center
In a new study, Moffitt Cancer Center researchers report on their identification of biomarkers based on a type of genetic modification called methylation that predicts the type of tumor immune environment and patient outcomes.
Read More
Biomarker in Liquid Biopsy for Lung Cancer Appears More Accurate in Predicting Immunotherapy Response Than Tumor Biopsy
The Tisch Cancer Institute at Mount Sinai
Mount Sinai researchers have validated for the first time that a liquid biopsy could be a better predictor of whether cancer immunotherapy will be successful for a patient with lung cancer than an invasive tumor biopsy.
Read More
Locking Cellular Escape Hatch for Leukemia
Duke Cancer Institute, Duke University Medical Center
After losing a close friend to acute myeloid leukemia, Kris Wood, PhD, devoted his research to helping find better treatment options for people with leukemias and lymphomas. He and his colleagues have discovered a potential new drug therapy that is preparing to enter clinical trials.
Read More
Study of Anti-Cancer Mitochondrial Drug Shows Additional Clinical Promise
Stony Brook Cancer Center
A study of the lead agent (CPI-613) in a class of anticancer drugs undergoing U.S. Food and Drug Administration approved clinical trials reveals that CPI-613 is effective against most carcinoma cell lines, and, used in combination, could have efficacy against reducing some tumors. The research was led by Paul M. Bingham, PhD.
Read More
Varenicline Increases Smoking Cessation Rates for African American Smokers
The University of Kansas Cancer Center
The University of Kansas Cancer Center researchers have released the results of a clinical trial that examined the effectiveness of varenicline in African Americans. In their study, African American daily smokers who were given varenicline while receiving counseling had significantly greater quit rates than those who received a placebo.
Read More
Age-Related Lung Changes Provide Pathway for Metastatic Growth of Dormant Melanoma Cancer Cells
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
New laboratory research directed by investigators at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Bloomberg School of Public Health finds that secreted age-induced changes in distant sites such as the lung can effectively reactivate dormant cells and cause them to grow.
Read More
Glioma Progression is Shaped by Genetic Evolution and Microenvironment Interactions
The Jackson Laboratory Cancer Center
The Glioma Longitudinal Analysis Consortium (GLASS) is investigating why gliomas develop resistance and recur. By analyzing tumor samples from patients before treatment then after recurrence, GLASS scientists, led by Roel Verhaak, PhD, are discovering how the brain tissue environment and the therapies themselves drive glioma cell changes that allow them to adapt and grow again.
Read More
Listeria-Based Booster Improves Vaccine Protection Against Recurring Colon Cancer
Sidney Kimmel Comprehensive Cancer Center at Jefferson
New research shows in an animal model that using viral and bacterial vaccine approaches together is safe and far more effective at fighting treatment-resistant cancer than either approach by itself.
Read More
Researchers Identify New Treatment Target for Prostate Cancer
Roswell Park Comprehensive Cancer Center
A team of researchers at Roswell Park, led by Dhyan Chandra, PhD, have uncovered evidence that could lead to the development of a new treatment option for patients with metastatic, resistant or recurrent prostate cancer. Their findings suggest that mitochondrial unfolded protein response could be a new target for the treatment and management of this patient population.
Read More
Social Stress Factors Drive Cancer Mechanisms That Help Explain Racial Disparities
Duke Cancer Institute, Duke University Medical Center
A Duke Cancer Institute study led by Gayathri Devi, PhD, finds chronic stresses such as racism and poverty alter cellular functions that promote tumor growth and proliferation.
Read More
Advanced Radiotherapy is Safe, Effective for Early-Stage Liver Cancer
The Tisch Cancer Institute at Mount Sinai
Researchers at the Icahn School of Medicine at Mount Sinai found that an advanced radiotherapy technique called radiation segmentectomy may be effective against very early to early-stage hepatocellular carcinoma (HCC). It is the first prospective study to explore the efficacy and outcomes of this technique. Results suggest it may be a curative treatment for inoperable, early-stage HCC.
Read More
Immunotherapy Before Surgery Associated With Improved Survival for Soft-Tissue Sarcoma
The University of Texas MD Anderson Cancer Center
In a Phase II clinical trial, immune checkpoint blockade before surgery was associated with favorable responses and outcomes in undifferentiated pleomorphic sarcoma and recurrent dedifferentiated liposarcoma, researchers from The University of Texas MD Anderson Cancer Center have reported.
Read More
Screening and Removal of Precancerous Lesions Prevents Anal Cancer
UCSF Helen Diller Family Comprehensive Cancer Center
A new study led by Joel Palefsky, MD, found that routine screening for and removal of precancerous anal lesions can significantly reduce the risk of anal cancer, similar to the way cervical cancer is prevented in women.
Read More
Study Reveals How Gastric Cancer Forms, Suggests Preventive Treatment
Vanderbilt-Ingram Cancer Center
Eunyoung Choi, PhD, and colleagues identified for the first time that Trop2+/CD133+/CD166+ dysplastic stem cells are a key source of clonal evolution of dysplasia to multiple types of gastric cancer. Their investigation further showed that pyrvinium blocked regeneration of dysplastic stem cells by controlling the CK1a signaling protein in mouse models and in human organoids.
Read More
Study Uncovers New Treatment Approaches for Liver Cancer Patients
Cedars-Sinai Cancer
Experts from Cedars-Sinai Cancer have analyzed patient samples, along with studies conducted in animal models, to identify a novel immune checkpoint pathway to treat hepatocellular carcinoma. The findings are centered on the discovery of a novel role for the IL-27 signaling pathway in liver cancer.
Read More
Researchers Help Find Mechanism Leading to Prostate Cancer Drug Resistance
Moffitt Cancer Center
Moffitt Cancer Center researchers have revealed a mechanism by which prostate cancer cells become resistant through molecular modification of the androgen receptor protein and identify a potential treatment approach that could overcome this resistance.
Read More
Back to News From the Centers
Groundbreaking for Major Expansion Celebrated
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
The University of Maryland Medical Center has broken ground for a $219 million, nine-story patient care tower—the Roslyn and Leonard Stoler Center for Advanced Medicine—that will become the new home of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. Kevin J. Cullen, MD, is the center's director.
Read More
Cancer Research Building Construction Begins
Sylvester Comprehensive Cancer Center, University of Miami
Sylvester Comprehensive Cancer Center is celebrating the groundbreaking for a 244,000-square-foot, state-of-the-art Sylvester Comprehensive Cancer Center - Transformational Cancer Research Building. The 12-story facility is slated to open in 2024.
Read More
Expanding Commitment to Advance Cancer Research in the Mountain West
Huntsman Cancer Institute at the University of Utah
Huntsman Cancer Institute at the University of Utah announces a formal expansion of its catchment area. In addition to Utah, it now includes Idaho, Montana, Nevada, and Wyoming. Neli Ulrich, PhD, MS, is the center's executive director.
Read More
Statewide Cancer Navigation Program Launched
UAMS Winthrop P. Rockefeller Cancer Institute
The UAMS Winthrop P. Rockefeller Cancer Institute is implementing a new statewide patient navigation program to help cancer patients across the state access needed prevention, screening, treatment and support services.
Read More
First Graduate of New Cancer Biology Concentration
Wilmot Cancer Institute, UR Medicine
Carlos Ortiz-Bonilla, a Puerto Rican native who has been studying science at the University of Rochester (UR) for the past seven years, is the first graduate of a new course concentration in cancer biology, spearheaded by the Wilmot Cancer Institute. The cancer biology concentration was developed in partnership with UR's doctoral programs.
Read More
Back to News From the Centers